A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 25251201)

Published in Am J Addict on September 22, 2014

Authors

Helen M Pettinati1, Kyle M Kampman, Kevin G Lynch, William D Dundon, Elizabeth M Mahoney, Michael R Wierzbicki, Charles P O'Brien

Author Affiliations

1: Department of Psychiatry, Center for the Studies of Addiction, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.

Articles by these authors

An international consensus for assessing internet gaming disorder using the new DSM-5 approach. Addiction (2014) 8.38

What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry (2006) 8.22

Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial. JAMA (2010) 3.94

The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66

Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA (2008) 3.64

A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology (2005) 3.53

Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA (2004) 3.48

Internet gaming disorder and the DSM-5. Addiction (2013) 3.46

Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA (2013) 3.25

Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry (2002) 3.22

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2006) 3.06

Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend (2006) 2.98

DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry (2013) 2.89

Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. Drug Alcohol Depend (2006) 2.89

Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure. Circulation (2005) 2.85

Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology (2007) 2.73

Causal mediation analyses with rank preserving models. Biometrics (2007) 2.67

Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med (2011) 2.65

Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry (2007) 2.60

Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. Am J Public Health (2005) 2.49

The status of disulfiram: a half of a century later. J Clin Psychopharmacol (2006) 2.48

Issues for DSM-V: should obesity be included as a brain disorder? Am J Psychiatry (2007) 2.48

The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Arch Gen Psychiatry (2005) 2.37

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry (2010) 2.34

Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am J Psychiatry (2014) 2.18

Prelude to passion: limbic activation by "unseen" drug and sexual cues. PLoS One (2008) 2.07

Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry (2007) 2.07

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol (2006) 2.00

Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA (2010) 1.97

The availability of web sites offering to sell opioid medications without prescriptions. Am J Psychiatry (2006) 1.93

The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes. J Consult Clin Psychol (2004) 1.82

Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr (2010) 1.79

A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend (2004) 1.75

Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74

A randomized trial of audio computer and in-person interview to assess HIV risk among drug and alcohol users in Rio De Janeiro, Brazil. J Subst Abuse Treat (2006) 1.72

A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl (2011) 1.69

Extended telephone-based continuing care for alcohol dependence: 24-month outcomes and subgroup analyses. Addiction (2011) 1.68

Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt) (2008) 1.67

Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat (2006) 1.63

Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J Am Coll Cardiol (2005) 1.61

Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis. Addiction (2012) 1.58

Multidimensional assessment of nicotine dependence in adolescents. Drug Alcohol Depend (2005) 1.56

Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial. Circ Cardiovasc Qual Outcomes (2009) 1.56

Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task. Drug Alcohol Depend (2002) 1.56

The relationship between alcohol and individual differences variables on attitudes and behavioral skills relevant to sexual health among heterosexual young adult men. Arch Sex Behav (2004) 1.53

Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend (2003) 1.50

A randomized trial of extended telephone-based continuing care for alcohol dependence: within-treatment substance use outcomes. J Consult Clin Psychol (2010) 1.50

Rapid relapse generally follows treatment for substance use disorders among adolescents. Addict Behav (2003) 1.48

Effects of varenicline on smoking cue–triggered neural and craving responses. Arch Gen Psychiatry (2011) 1.45

Reliability and validity of the alcohol short index of problems and a newly constructed drug short index of problems. J Stud Alcohol Drugs (2009) 1.45

Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav (2002) 1.44

Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob Res (2004) 1.37

A randomized clinical trial of alcohol care management delivered in Department of Veterans Affairs primary care clinics versus specialty addiction treatment. J Gen Intern Med (2013) 1.37

Naltrexone for heroin dependence treatment in St. Petersburg, Russia. J Subst Abuse Treat (2004) 1.35

Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry (2013) 1.33

DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology (2008) 1.31

Conceptual, methodological, and analytical issues in the study of relapse. Clin Psychol Rev (2005) 1.30

The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend (2009) 1.30

Acceptability of audio computer-assisted self-interview (ACASI) among substance abusers seeking treatment in Rio de Janeiro, Brazil. Drug Alcohol Depend (2006) 1.28

Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence. J Clin Psychiatry (2014) 1.26

A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet (2003) 1.25

Mediators of telephone-based continuing care for alcohol and cocaine dependence. J Consult Clin Psychol (2007) 1.19

Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat (2007) 1.18

A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend (2006) 1.17

Physical and sexual abuse, depression and alcohol use disorders in adolescents: onsets and outcomes. Drug Alcohol Depend (2003) 1.16

Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. Addict Biol (2011) 1.16

A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcohol Clin Exp Res (2008) 1.15

Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14

A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addict Behav (2007) 1.11

Alcohol potentiates hepatitis C virus replicon expression. Hepatology (2003) 1.11

Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample. Drug Alcohol Depend (2012) 1.10

A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat (2012) 1.10

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol (2007) 1.10

Childhood abuse as a risk factor for suicidal behavior in borderline personality disorder. J Pers Disord (2002) 1.07

Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes. Alcohol Clin Exp Res (2002) 1.06

Addiction Severity Index Recent and Lifetime summary indexes based on nonparametric item response theory methods. Psychol Assess (2007) 1.06

Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone. Addict Biol (2006) 1.06